Accelerating Pharmaceutical Development
Creating an effective therapeutic does not end with the identification of a compound with high activity and specificity against a protein target. The pharmaceutical needs a delivery vehicle that safely and efficiently treats the disease within a patient. Identifying the right solid form of the drug, in terms of different polymorphs or crystal morphology can significantly decrease the time required to develop the final product formulation and avoid costly late-stage project failures.
BIOVIA Materials Studio provides a comprehensive suite of methods to model the behavior of drug compounds in silico, which can help to guide development efforts, minimizing risk and supporting IP capture.
The world of product development is changing. Stay ahead of the competition with BIOVIA.
Speak with a BIOVIA expert to learn how our solutions enable seamless collaboration and sustainable innovation at organizations of every size.
Courses and classes are available for students, academia, professionals and companies. Find the right BIOVIA training for you.
Find information on software & hardware certification, software downloads, user documentation, support contact and services offering